NVS

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

04/01 01:00 pm

Proleukin Market Research Report 2026-2035: Epidemiology, Pipeline Analysis, Industry Insights and More

04/01 04:43 am

Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health

03/30 01:33 pm

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

03/30 08:00 am

Teva gewinnt an Dynamik im Biosimilar-Geschäft mit der FDA-Zulassung für PONLIMSI™ (Denosumab-adet) und der Annahme von parallelen Zulassungsanträgen für einen Biosimilar-Kandidaten zu Xolair® (Omalizumab)

03/30 08:00 am

Teva gagne du terrain dans le domaine des médicaments biosimilaires grâce à l’approbation accordée par la FDA pour PONLIMSI™ (dénosumab-adet) et à l’acceptation d’un double dossier pour un candidat biosimilaire à Xolair® (omalizumab)

03/30 08:00 am

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

03/30 05:00 am

Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook

03/30 04:58 am

Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%

03/29 01:15 am

Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline

03/27 12:54 pm

International ETFs: EEM and IEFA Offer Distinct Global ETF Choices

03/27 10:08 am

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors

03/27 02:05 am

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

03/27 02:00 am

Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst

03/25 11:20 am

Merck Nears $6 Billion Deal To Buy Terns Pharma: Report

03/25 05:38 am

Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF

03/24 03:15 pm

Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs

03/23 08:00 am

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

03/23 05:00 am

Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026

03/23 02:15 am

Novartis Strikes $3 Billion Deal For Next-Gen Breast Cancer Drug

03/20 10:52 am

Amphista Therapeutics appoints Louise Modis Ph.D. as CEO and Patrick Kelly M.D. as CMO and provides a business update as the Company prepares to file IND application for AMX-883

03/18 08:00 am

Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients

03/16 09:42 am

Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics

03/16 07:00 am

Skeletal Dysplasia Market - Global Forecast 2026-2032: $5.37 Bn Opportunities Driven by Advancing Diagnostic Precision, Integrated Therapies, Evidence Generation, and Equitable Access

03/05 05:51 am

Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

03/05 05:44 am

Your Kidneys Count: American Kidney Fund Urges Americans to Protect Their Health this Kidney Month

02/27 10:52 am

Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

02/25 01:54 pm

Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036

02/25 10:00 am

Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?

02/24 05:32 pm

Stock Market Today, Feb. 23: Novo Nordisk Plunges 16% After Obesity Drug Falls Short

02/23 06:21 pm

PSMA-Targeted Therapy & Radiodiagnostics Competitor Analysis Report 2026: PYLARIFY Exceeds US$ 1 Billion in Net Sales and Became the First Ever Blockbuster Radiodiagnostic

02/20 11:55 am

Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider

02/18 06:55 am

Novartis Says Conditionally Approved Kidney Drug Shows Long-Term Promise

02/13 09:07 am

Hepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally

02/11 05:00 am

Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead

02/04 01:25 pm

This Vanguard ETF Has Doubled the S&P 500's Returns Since the Start of 2025. Is It a Buy Now?

02/03 01:15 pm

Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

02/03 02:56 am

Even Near an All-Time High, This Dividend ETF Looks Extremely Cheap

01/31 02:03 pm

Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

01/28 06:51 am

Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica

01/27 02:43 pm

Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

01/27 11:00 am

Why I Am Buying the Schwab International Equity ETF (SCHF) and Never Looking Back

01/27 09:27 am

Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag

01/26 11:06 am

Corticosteroids Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

01/26 05:51 am

Novartis Positions US Strategy As Defense Against Rising Trade Levies

01/23 11:57 am

Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

01/23 06:52 am

High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

01/21 12:00 pm

Actionable Insights in the Dermatology Market: Navigating Technological Advances and Growth Trends

01/16 05:56 am

Generalized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | DelveInsight

01/14 02:00 pm

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

01/13 02:00 pm